Daily Cannabis News Brief for 10/29/2026

Below is The Marijuana Herald’s Daily Cannabis News Brief for October 29, 2026, sponsored by Trulieve. The Marijuana Herald publishes a new edition every weekday at around 3 p.m. Pacific Time. Previous editions can be found by clicking here.

U.S. Congressmember Steve Cohen Introduces Bill to Deschedule Marijuana, Eliminate Mandatory Minimums and Overhaul Federal Drug Laws

Congressman Steve Cohen (D-TN) introduced legislation Thursday that would remove marijuana entirely from the federal Controlled Substances Act, eliminate mandatory minimum sentences for federal drug offenses and establish a new drug scheduling framework. The proposal would also transfer substantial scheduling authority from the DEA to the Department of Health and Human Services, expand research protections and allow certain previously sentenced individuals to request resentencing.

Congressional Cannabis Caucus Co-Chair Rep. Dina Titus Backs New Bill to Deschedule Marijuana and Overhaul Federal Drug Laws in Exclusive Statement

Congressional Cannabis Caucus Co-Chair Representative Dina Titus (D-NV) endorsed newly introduced legislation from Representative Steve Cohen (D-TN) that would remove marijuana from the federal Controlled Substances Act, eliminate mandatory minimum drug sentences and overhaul federal drug scheduling laws. In an exclusive statement provided Thursday to The Marijuana Herald, Titus praised the proposal, saying “the federal government must catch up to the states” and calling for federal laws to recognize the legitimate marijuana industry and its medical benefits.

Study of Over 8,300 Chronic Pain Patients Finds Medical Marijuana Use Linked to Twice the Rate of Opioid Prescription Discontinuation

A study published in the Journal of Addiction Medicine involving 8,358 chronic pain patients found that those receiving medical marijuana for more than 30 days were approximately twice as likely to discontinue prescription opioids as those receiving marijuana for shorter periods. Opioid prescriptions were discontinued by 15.5% of longer-duration patients, compared with 7.6% of those receiving marijuana for 30 days or less.

Michigan Expands Marijuana Terpene Reporting Options, Adding Nine Compounds Beginning November 11

Michigan is expanding its marijuana testing reporting system to support nine additional terpenes and a new total-terpenes measurement beginning November 11. Announced in an October 28 industry bulletin, the changes will allow laboratories to provide more detailed chemical profiles for marijuana flower, infused products, beverages and certain vaporizers without imposing additional mandatory testing requirements.

Study Finds New CBD Formulation Increases Skin Absorption Sevenfold and Reduces Inflammatory Markers

Researchers in Spain developed a new cannabidiol (CBD) formulation that delivered approximately seven times more CBD into reconstructed human skin after 24 hours than conventional CBD oil. Published in the journal Cosmetics, the study also found substantial reductions in inflammation-related proteins, including decreases of 93% and 73% in IL-6 and IL-8 production in laboratory experiments.

Congressional Researchers Confirm FDA Still Hasn’t Published Federally Required Cannabinoid Lists as Hemp Restrictions Approach

A new Congressional Research Service report confirms that the Food and Drug Administration (FDA) has not published cannabinoid classification lists or packaging guidance required by federal law, despite a February deadline. The findings come ahead of new hemp restrictions scheduled for November 12 and broader changes taking effect December 11, leaving important regulatory questions unresolved for businesses and consumers.

Study Finds Silver Particles Made With Marijuana Extract Enhance Antibiotics Against Drug-Resistant Bacteria

A laboratory study found that silver particles produced using marijuana leaf extract significantly enhanced the antibacterial activity of two commonly prescribed antibiotics against drug-resistant bacteria. Researchers observed synergistic effects when combining the particles with cefotaxime and meropenem against E. coli and Salmonella typhi, suggesting a potential avenue for developing new antimicrobial treatments.

California Seizes More Than $230 Million in Illegal Marijuana in 2026, Eradicates Nearly 237,000 Plants

California authorities seized or destroyed more than $230 million worth of illegal marijuana during the first nine months of 2026, according to figures released Thursday by Governor Gavin Newsom (D). Enforcement operations resulted in 139,293 pounds of marijuana seized or destroyed and 236,846 plants eradicated, bringing the state’s estimated total value of illegal marijuana seized or destroyed since 2022 to $1.47 billion.

Federal Government Proposes Changes to Workplace Drug Testing Procedures in New Federal Register Notice

The Department of Health and Human Services published proposed changes to federal workplace drug testing procedures in Thursday’s Federal Register, including reducing certain initial laboratory quality-control requirements from 10% to 4% and revising procedures for questionable urine specimens. The proposals cover testing programs that include marijuana, although existing THC testing cutoff levels would remain unchanged. Public comments will be accepted through December 28.

Verano Reports $212 Million in Third-Quarter Revenue, With Operating Cash Flow Reaching Four-Year High

Verano Holdings reported $212.4 million in third-quarter revenue, a 5% increase from the same period last year, while generating $49 million in operating cash flow, its highest quarterly total in four years. The multistate marijuana company’s net loss narrowed significantly from $43.8 million to $4.1 million, while its retail network expanded to 163 dispensaries across 13 states.

New York Governor Signs Marijuana Labor Bill, Agrees to Eliminate Proposed Industry Wage Board

New York Governor Kathy Hochul (D) signed legislation eliminating the requirement that licensed marijuana businesses maintain labor peace agreements with unions. Hochul also reached an agreement with legislative leaders to remove provisions establishing a marijuana industry wage board and additional financial disclosure requirements, although those changes will require further legislative action before their scheduled January 31 implementation.

Study: CBD Alters Genes Involved in Cellular Stress and Cholesterol Metabolism in Human Cells

A study published Thursday in the Journal of Molecular Pathology found that CBD influences gene activity associated with cellular stress responses, cholesterol regulation and lipid metabolism across five types of human cells. Researchers identified 22 genes affected across all five cell types, with additional changes varying by cell type, providing new insight into the molecular mechanisms underlying CBD’s biological effects.